chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 1.0
Sex: U
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a consumer concerning her 12 month old child who on an unspecified date was vaccinated with the first dose of VARIVAX (Merck) (LOT # not reported).  On an unknown date the patient experienced rash.  The patient's outcome was unknown at the time of the report.  This is one of the two reports from the same source.  Additional information has been requested.
Age: 28.0
Sex: F
Vaccine: MMR
Symptoms: Mumps antibody test negative, No therapeutic response
Clinical narrative: Information has been received from a licensed physical therapist assistant concerning herself, a 28 year old female with a history of blood pressure high who was vaccinated with MMR II (lot number, route an site of administration not reported) as a child. There were no history of drug reactions and allergies. Concomitant therapy included NORVASC. The reporter stated that her titer for mumps was low now, she did not know how many doses of MMR II she has received in the past. the patient did not seek medical attention. At the time of reporting, the patient's mumps titer was still low. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Hypersensitivity
Clinical narrative: Information has been received from a registered nurse concerning a 4 year old male who was vaccinated with a dose of MMR II. The mother of the patient said he had a "severe reaction" after receiving MMR II. The patient sought unspecified medical attention. The patient's outcome was unknown. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site discolouration, Injection site erythema, Injection site oedema, Injection site pain, Injection site rash
Clinical narrative: Information has been received from a physician concerning a couple patients with no pertinent medical history who were vaccinated with the second 0.5ml doses of VARIVAX (Merck) (lot# not reported).  The patients had pain and swelling at the injection site after getting their second doses of VARIVAX (Merck).  None of the patients had an adverse event after their first doses of VARIVAX (Merck).  No lab diagnostic study was performed.  The patients sought unspecified medical attention.  At the time of the report, the patients' outcomes were unknown.  Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report.  Additional information will be provided if available.  All telephone attempts to obtain follow-up information have been unsuccessful.  Follow up information has been received from a physician concerning a 5 year old male patient with no known medical history who on 20-NOV-2009 received a second dose of VARIVAX (Merck) (Lot # 665090/1037Y) SC, left arm.  No concomitant medication.  On 22-NOV-2009 the patient developed a rash at site of injection, dark in center and redness around that, slightly edematous, no tenderness, no itch, no fever.  The patient was treated with ice and BENADRYL each 6 hours as needed.  At the time of this report, the patient was recovered.  Additional information is not expected.
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site swelling, No reaction on previous exposure to drug
Clinical narrative: Information has been received from a physician concerning a couple patients with no pertinent medical history who were vaccinated with the second 0.5ml doses of VARIVAX (Merck) (lot# not reported).  The patients had pain and swelling at the injection site after getting their second doses of VARIVAX (Merck).  None of the patients had an adverse event after their first doses of VARIVAX (Merck).  No lab diagnostic study was performed.  The patients sought unspecified medical attention.  At the time of the report, the patients' outcomes were unknown.  Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report.  Additional information will be provided if available.  All telephone attempts to obtain follow-up information have been unsuccessful.  Follow up information has been received from a physician concerning a 5 year old male patient with no known medical history who on 20-NOV-2009 received a second dose of VARIVAX (Merck) (Lot # 665090/1037Y) SC, left arm.  No concomitant medication.  On 22-NOV-2009 the patient developed a rash at site of injection, dark in center and redness around that, slightly edematous, no tenderness, no itch, no fever.  The patient was treated with ice and BENADRYL each 6 hours as needed.  At the time of this report, the patient was recovered.  Additional information is not expected.
Sex: F
Vaccine: MMR
Symptoms: No therapeutic response
Clinical narrative: Information has been received from a medical assistant concerning a female with neck strain and pharyngitis who in the past was vaccinated with MMR II. Concomitant therapy included CELEXA, KLONOPIN, rizatriptan benzoate and REGLAN. The patient had low titers for mumps. The mumps IgG was 0.33 and the mumps IgM was 0.36. The patient did not seek any medical attention. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Body temperature increased, Pyrexia, Rash morbilliform, Rash rubelliform
Clinical narrative: Information has been received from a physician's assistant concerning a 13 month old female patient who on an unspecified date was vaccinated with 0.5 ml of dose of MMR II (lot not required). On the same visit the patient also received VARIVAX. Subsequently the patient developed rubella and measles type rash all over the body and fever above 101 degree. Additional information has been requested.
Age: 14.0
Sex: M
Vaccine: VARCEL
Symptoms: Abdominal pain upper, Cough, Dizziness, Headache, Pyrexia
Clinical narrative: Information has been received from a medical assistant concerning a 14 year old male patient with no pertinent medical history and no known allergies who on 17-AUG-2009 was vaccinated SQ with the first 0.5 ml dose of VARIVAX (Merck) (lot number 660407/0103X). On 21-AUG-2009 the patient developed a fever and dizziness. On 24-AUG-2009 the patient was examined in the office. There were no lab studies performed. There was no treatment was prescribed. On an unspecified date, the patient had subsequently recovered. Follow-up information has been received from the medical assistant. On 21-AUG-2009 the patient developed running fever, dizziness, fever, stomach pain, headache, coughing and rash on his back of legs. The outcome of the patient was reported as unknown. Additional information has been requested.
Age: 14.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a medical assistant concerning a 14 year old male patient with no pertinent medical history and no known allergies who on 17-AUG-2009 was vaccinated SQ with the first 0.5 ml dose of VARIVAX (Merck) (lot number 660407/0103X). On 21-AUG-2009 the patient developed a fever and dizziness. On 24-AUG-2009 the patient was examined in the office. There were no lab studies performed. There was no treatment was prescribed. On an unspecified date, the patient had subsequently recovered. Follow-up information has been received from the medical assistant. On 21-AUG-2009 the patient developed running fever, dizziness, fever, stomach pain, headache, coughing and rash on his back of legs. The outcome of the patient was reported as unknown. Additional information has been requested.
Age: 1.25
Sex: F
Vaccine: MMR
Symptoms: Rash
Clinical narrative: Information has been received from a medical assistant cornering a 15 month old female who on 16-OCT-2009 was vaccinated with a dose of MMR II. Concomitant therapy included "ENDOCIL", PREVNAR and "Flu vaccine". On 26-OCT-2009 the patient experienced a rash on her head and chest. The patient sought unspecified medical attention. At the time of this report, the patient had not recovered. Follow up information was received from the physician who indicated that the child was vaccinated with the first SQ dose of MMR II (lot No. 663929/0511Y) in her right arm. Concomitant vaccination included PENTACEL. On 25-OCT-2009 the child developed rash on her face and chest; no fever or other symptoms were noted. At the time of the report, the outcome of the patient was unknown. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: IPV, MMR, VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a consumer concerning her 4 year old son with no pertinent medical history and no known allergies who on 25-AUG-2009 was vaccinated with a dose of VARIVAX (Merck) (lot number not reported).  Secondary suspect vaccination therapy on the same day included a dose of MMR II (lot number not reported).  Concomitant therapy on the same day included poliovirus vaccine (manufacturer unspecified).  On 06-SEP-2009 the patient developed several chickenpox-like spots and on 07-SEP-2009 was covered in chickenpox.  Unspecified medical attention was sought.  There were no lab studies performed.  At the time of the report, the patient not recovered.  Additional information has been requested.
Age: 2.0
Sex: F
Vaccine: MMR
Symptoms: Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning an 15 year old female who on 29-AUG-1994 was vaccinated with the first dose of MMR II, on 14-Oct-1994 was vaccinated with the second dose of MMR II.  On 11-NOV-2009 the patient experienced mumps.  Diagnosis on 10-DEC-2009 revealed the patient had parotitis R and the patient was afebrile.  Follow-up information was received which reported that on 03-JAN-2010 the patient experienced mumps.  Diagnosis on 03-JAN-2010 revealed the patient had parotitis R.  Follow-up information was received which indicated the patient was 18 year old (also reported as 10 year old) at the time of the event.  Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Mumps, Parotitis, Skin swelling
Clinical narrative: Information has been received from a physician concerning an 11 year old male who on 18-OCT-1999 was vaccinated with the first dose of MMR II, on 13-Feb-2002 was vaccinated with the second dose of MMR II.  On 12-DEC-2009 the patient experienced mumps.  Diagnose on 27-NOV-2009 revealed the patient had parotitis L and the patient was afebrile.  Other symptoms included swelling under left ear.  Follow-up information was received which reported that on 07-DEC-2009 the patient experienced mumps.  Diagnose on 8-DEC-2009 revealed the patient's body temperature was 102 degree F, the patient had parotitis R.  Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Mumps, Parotitis, Vomiting
Clinical narrative: Information has been received from a physician concerning an 14 year old male patient who on 11-Sep-1996 was vaccinated with the first dose of MMR II, on 06-May-1999 was vaccinated with the second dose of MMR II.  On 10-NOV-2009 the patient experienced mumps.  Diagnose on 31-DEC-2009 revealed the patient had parotitis L and the patient was afebrile.  Other symptoms included vomiting once.  Follow-up information was received which reported that on 12-NOV-2009 the patient experienced mumps.  Diagnose on 12-NOV-2009 revealed the patient had parotitis R and the patient was afebrile. Additional information has been requested.
Age: 7.0
Sex: M
Vaccine: VARCEL
Symptoms: Face oedema, Scab, Skin lesion, Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning a 7 year old male patient with no pertinent medical history and no drug reactions/allergies who on 18-DEC-2008 was vaccinated with the first dose of VARIVAX (Merck) (lot #641709/0330M), and on 27-APR-2009 received the second dose of VARIVAX (Merck) (lot #652456/1019R). There was no concomitant medication. It was reported on 21-AUG-2009 experienced chicken pox. The patient developed a few lesions and by the next morning he had 50 - 500 lesions covering his body and a fever. The patient was seen by his primary care physician on 24-AUG-2009 with lesions crusting over. The doctor confirmed diagnosis of chicken pox. There were no complications and no treatment was required. No lab tests were performed. On an unspecified date. the patient had recovered and had returned to school. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase increased, Mumps, Parotitis, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 20 year old male patient who was vaccinated with the first and second dose of MMR II respectively on 15-JAN-1991 and on 02-SEP-1993.  On 09-NOV-2009 the patient developed afebrile mumps.  The patient was diagnosed on 11-NOV-2009.  The patient's fever count was 9 and his Parotitis was bilateral; count 8.  On 11-NOV-2009 the patient's serum immunoglobulin M (IgM) was negative, serum immunoglobulin G (IgG) was 6.14 and serum amylase was 443.  The outcome of the patient was not reported.  Follow-up information has been received concerning the patient who on 11-DEC-2009 (previously reported as 11-NOV-2009) was diagnosed.  The patient's Parotitis was on the left side (previously reported as bilateral).  The first blood work was refused (previously reported as has performed).  This is one of several reports from the same source.  Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Abdominal pain upper, Auricular swelling, Blood amylase increased, Blood immunoglobulin G decreased, Mumps
Clinical narrative: Information has been received from a physician concerning a 12 year old male patient who was vaccinated with the first and second dose of MMR II respectively on 16-FEB-1999 and on 06-FEB-2002. On 15-NOV-2009 the patient developed afebrile mumps and stomach ache. The patient was diagnosed on 14-DEC-2009. The patient's fever count was 65 and his parotitis was on left side; count 81. On 14-DEC-2009 the patient's serum immunoglobulin G (IgG) was 10.07 and serum amylase was 73. The outcome of the patient was not reported. Follow-up information was received which reported that on 21-JAN-2010, the patient developed right parotitis with swelling under right ear. There was no other symptom. It was diagnosed on 22-JAN-2010. On 22-JAN-2010, the patient's serum immunoglobulin G (IgG) was 6.9 and serum amylase was 131. The outcome of the patient was not reported. This is one of several reports from the same source. Additional information is not expected.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Parotitis, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 12 year old male patient who was vaccinated with the first and second dose of MMR II respectively on 16-FEB-1999 and on 06-FEB-2002. On 15-NOV-2009 the patient developed afebrile mumps and stomach ache. The patient was diagnosed on 14-DEC-2009. The patient's fever count was 65 and his parotitis was on left side; count 81. On 14-DEC-2009 the patient's serum immunoglobulin G (IgG) was 10.07 and serum amylase was 73. The outcome of the patient was not reported. Follow-up information was received which reported that on 21-JAN-2010, the patient developed right parotitis with swelling under right ear. There was no other symptom. It was diagnosed on 22-JAN-2010. On 22-JAN-2010, the patient's serum immunoglobulin G (IgG) was 6.9 and serum amylase was 131. The outcome of the patient was not reported. This is one of several reports from the same source. Additional information is not expected.
Age: 1.09
Sex: M
Vaccine: MMR
Symptoms: Mumps, Parotitis, Swelling face, Vomiting
Clinical narrative: Information has been received from a physician concerning a 9 (also reported as 17) year old male who on 15-MAY-2001 was vaccinated with the first dose of MMR II.  On 30-DEC-2009 the patient experienced mumps.  Date of mumps diagnosis reported as 25-NOV-2009.  The patient was afebrile.  The patient had left and right parotitis.  Parotitis count was 72.  On 25-NOV-2009 the first blood work revealed IgM < 1:10, IgG 4.58, and serum amylase 73.  At the time of this report, the patient's outcome was not reported.  Follow-up information was received from the physician indicating that on 16-NOV-2009, the patient developed mumps.  It was diagnosed on 16-NOV-2009 that the patient had left facial swelling and right parotitis.  The patient also experienced vomiting.  On 16-NOV-2009, the first blood work revealed IgM < 1:10, IgG 2.05, and serum amylase 63.  No further information is available.
Age: 3.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase increased, Blood immunoglobulin M, Laboratory test abnormal, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 9 year old male who on 06-FEB-2002 was vaccinated with the first dose of MMR II. On 21-JUN-2004, the patient was vaccinated with the second dose of MMR II. On 02-JAN-2010, the patient experienced mumps. Date of mumps diagnosis reported as 31-DEC-2009. The patient was afebrile. The patient had right parotitis. Parotitis count was 122. At the time of this report, the patient's outcome was not reported. Follow-up information was received from the physician indicating that on 06-DEC-2009 the 8 year old patient developed mumps. The date diagnosed was changed to 07-DEC-2009. The patient had left parotitis. On 07-DEC-2009 the first blood work revealed IgM<1:10, IgG 8.12 and serum amylase 397. No further information is available.
Age: 3.0
Sex: M
Vaccine: MMR
Symptoms: Pyrexia
Clinical narrative: Information has been received from a physician concerning a 9 year old male who on 06-FEB-2002 was vaccinated with the first dose of MMR II. On 21-JUN-2004, the patient was vaccinated with the second dose of MMR II. On 02-JAN-2010, the patient experienced mumps. Date of mumps diagnosis reported as 31-DEC-2009. The patient was afebrile. The patient had right parotitis. Parotitis count was 122. At the time of this report, the patient's outcome was not reported. Follow-up information was received from the physician indicating that on 06-DEC-2009 the 8 year old patient developed mumps. The date diagnosed was changed to 07-DEC-2009. The patient had left parotitis. On 07-DEC-2009 the first blood work revealed IgM<1:10, IgG 8.12 and serum amylase 397. No further information is available.
Age: 3.0
Sex: M
Vaccine: MMR
Symptoms: Headache, Mumps, Pain in jaw
Clinical narrative: Information has been received from a physician concerning an 8 year old male who on 06-AUG-2002 and 06-APR-2004 was vaccinated with the first and second doses of MMR II. On 07-DEC-2009 the patient experienced mumps. On 19-NOV-2009 the patient had the first blood work, serum immunoglobulin G was 2.11, serum immunoglobulin M was negative, serum amylase was 53. On 19-Nov-2009 the patient was diagnosed with Mumps. The patient had no fever. At the time of this report the patient's status was unknown. Follow up information from the physician indicated that the patient experienced mumps on 15-DEC-2009 (previously reported as 07-DEC-2009) . On 16-DEC-2009 the patient was diagnosed with Mumps. The patient had a headache and lower jaw pain for 1 day. On 17-DEC-2009, a first blood work was performed. Additional information has been requested.
Age: 3.0
Sex: M
Vaccine: MMR
Symptoms: Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 13 year old male who on 22-SEP-1997 and 30-Jul-2000 was vaccinated with the first and second doses of MMR II.  On 25-NOV-2009 the patient experienced mumps.  On 06-DEC-2009 the patient was diagnosed with mumps.  The patient was afebrile.  A sibling in the household also had mumps.  At the time of the report the status of the patient was unknown.  Follow up information from the physician indicated that the patient experienced mumps on 11-JAN-2010 (previously reported as 25-NOV-2009).  On 12-JAN-2010, the patient was diagnosed and had right parotitis.  On 12-JAN-2010, a first blood work was performed and showed that: IgM, <1:10; IgG, 10.72; serum amylase, 44.  Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Mumps
Clinical narrative: Information has been received from a physician concerning a 9 year old male who on 02-JAN-2002 and 05-JAN-2005 was vaccinated with the first and second doses of MMR II.  On 08-DEC-2009 the patient experienced mumps.  At the time of this report the patient's status was unknown.  Follow up information has been received from a physician reported that on 04-NOV-2009 the patient experienced mumps.  On 04-NOV-2009 the patient was diagnosed with mumps and was afebrile, it was also reported that the patient was 11 years old at the time of onset.  On 04-NOV-2009 the patient had the first blood work, serum immunoglobulin G is 9.39, serum immunoglobulin M<1:10.  Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase normal, Body temperature increased, Cough, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning an 18 year old male who on 22-APR-1993 and 08-OCT-1997 was vaccinated with the first and second doses of MMR II.  On 09-NOV-2009 the patient experienced mumps.  On 16-NOV-2009 the patient was diagnosed with mumps.  On 16-NOV-2009 the patient had the first blood work, serum immunoglobulin G is 2.05, serum immunoglobulin M<1:10, serum amylase is 63.  The patient did not have a fever.  The patient did experience symptoms of cough and congestion.  At the time of this report the patient status was unknown.  Follow up information has been received from a physician reported that on 15-DEC-2009 the patient experienced mumps.  On 18-DEC-2009 the patient was diagnosed with mumps.  The patient developed right parotitis and a temperature of 100 degrees F.  On 08-DEC-2009 the patient had the first blood work, serum immunoglobulin G is 2.14, serum immunoglobulin M<1:10, serum amylase is 39.  Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Pyrexia, Respiratory tract congestion
Clinical narrative: Information has been received from a physician concerning an 18 year old male who on 22-APR-1993 and 08-OCT-1997 was vaccinated with the first and second doses of MMR II.  On 09-NOV-2009 the patient experienced mumps.  On 16-NOV-2009 the patient was diagnosed with mumps.  On 16-NOV-2009 the patient had the first blood work, serum immunoglobulin G is 2.05, serum immunoglobulin M<1:10, serum amylase is 63.  The patient did not have a fever.  The patient did experience symptoms of cough and congestion.  At the time of this report the patient status was unknown.  Follow up information has been received from a physician reported that on 15-DEC-2009 the patient experienced mumps.  On 18-DEC-2009 the patient was diagnosed with mumps.  The patient developed right parotitis and a temperature of 100 degrees F.  On 08-DEC-2009 the patient had the first blood work, serum immunoglobulin G is 2.14, serum immunoglobulin M<1:10, serum amylase is 39.  Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 8 year old male patient who on 13-MAR-2004 and 25-AUG-2005 was vaccinated with the first and the second doses of MMR II respectively.  On 21-DEC-2009 the patient experienced mumps.  The patient had no fever.  The parotitis was on the right side.  The parotitis count was 13.  The date of mumps diagnosis was 08-DEC-2009.  The patient was exposed to a classmate with mumps.  On 08-DEC-2009 lab diagnostics revealed the patient's IgM was 0.64, IgG was 5.62 and serum amylase was 347.  At the time of report the patient's status was unknown.  Follow-up information has been received from a physician concerning an 8 year old male patient who on 15-MAR-2004 and 25-AUG-2005 was vaccinated with the first and the second doses of MMR II respectively.  On 11-JAN-2010 the patient experienced mumps.  The date of mumps diagnosis was 12-JAN-2010.  The patient was had right parotitis and was afebrile.  On 12-JAN-2010 lab diagnostics revealed the patient's IgM < 1:10, IgG was 7.55 and serum amylase was 54.  Additional information has been requested.
Age: 5.0
Sex: F
Vaccine: MMR
Symptoms: Headache, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 14 year old female patient who on 26-FEB-2000 was vaccinated with MMR II (HSA route, site, dose and lot number was not reported). On 30-NOV-2009 the patient experienced mumps (the date of diagnosis was reported as 04-DEC-2009). The first blood work done on 04-DEC-2009 included serum IgM <1:10, serum IgG 5.13 and serum amylase 129. The patient's symptoms included right parotitis and headache for 2 days. The outcome for mumps was not reported. This is one of several reports from the same source. No further information is available.
Age: 19.0
Sex: M
Vaccine: MMR
Symptoms: Mumps, Parotitis, Swelling
Clinical narrative: Information has been received from a physician concerning a 19 year old male patient who was vaccinated with MMR II. On 15-DEC-2009 the patient developed left parotitis. She was diagnosed with mumps on 15-DEC-2009. The patient did not have a fever. Blood works were performed on 15-DEC-2009. The serum immunoglobulin M test result was < 1:10. The serum immunoglobulin G was 4.47 and the serum amylase was 71. At the time of the report, the patient's outcome was unknown. Follow up information was received from the physician. It was reported on 01-DEC-2009 the patient developed parotitis on both side. She was diagnosed with mumps on 04-DEC-2009. The patient was afebrile. The patient had swelling under both ears. Blood works were performed on 04-DEC-2009. The serum immunoglobulin M test result was < 1:10. The serum immunoglobulin G was 5.68 and the serum amylase was 322. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
Age: 6.0
Sex: F
Vaccine: MMR
Symptoms: Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 16 year old female who on 21-OCT-1996 and 07-MAR-2000 was vaccinated with the first and second dose of MMR II (HSA) respectively. On 22-NOV-2009 the patient developed mumps. She was diagnosed on 02-DEC-2009. The patient did not have a fever. It was noted that the patient had right parotitis. Blood works were performed on 02-DEC-2009. The serum immunoglobulin M test result was 0.34. The serum immunoglobulin G was 5.69 and the serum amylase was 66. At the time of the report, the patient's outcome was unknown. Follow-up information was received from the physician indicating that on 09-NOV-2009 the patient developed mumps. It was noted that the patient had left parotitis. Blood work on 11-NOV-2009 revealed IgM negative, IgG 4.66 and serum amylase 195. No further information is available.
Age: 2.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase normal, Body temperature normal, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 13 year old male who on 24-DEC-1998 was vaccinated with first dose of MMR II (HSA route, site, dose and lot number not reported). On 04-DEC-2009 the patient experienced mumps (the diagnosis date was reported as 03-JAN-2010). The patient was febrile and had left parotitis. The outcome for mumps was not reported. Follow-up information was received from a physician. It was reported that the 17 year old (previously reported as 13 year old) patient experienced mumps on 05-DEC-2009. The diagnosis date was on 07-DEC-2009. On the same date, the patient had several tests performed: IgM was <1:10, IgG was 1.69 and serum amylase was 189. The patient was afebrile and had right parotitis. At the time of reporting, the patient's outcome was unknown. This is one of several reports from the same source. Additional information is not expected.
Age: 11.0
Sex: F
Vaccine: MMR
Symptoms: Blood amylase increased, Blood immunoglobulin M, Body temperature increased, Haematochezia, Mumps
Clinical narrative: Information has been received from a physician concerning a 13 year old female patient with a history of exposure to mumps who on 25-OCT-2007 was vaccinated with the first dose of MMR II (lot number not reported). On 31-DEC-2009 the patient experienced mumps. On an unspecified date, the patient developed fever of 103 F and blood in stool which lasted for 1 day. The patient was diagnosed on 24-DEC-2009. The patient experienced parotitis. On 24-DEC-2009. The patient's IgM was <1:10, her IgG was 5.68 and her serum amylase was 346. The outcome of the patient was not reported. Follow-up information was received which reported that on 11-JAN-2010, the patient developed afebrile bilateral parotitis. It was diagnosed on 11-JAN-2010. On 11-JAN-2010, the patient's IgM was <1:10, serum immunoglobulin G (IgG) was 7.09 and serum amylase was 65. The outcome of the patient was not reported. This is one of several reports from the same source. Additional information is not expected.
Age: 11.0
Sex: F
Vaccine: MMR
Symptoms: Parotitis, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 13 year old female patient with a history of exposure to mumps who on 25-OCT-2007 was vaccinated with the first dose of MMR II (lot number not reported). On 31-DEC-2009 the patient experienced mumps. On an unspecified date, the patient developed fever of 103 F and blood in stool which lasted for 1 day. The patient was diagnosed on 24-DEC-2009. The patient experienced parotitis. On 24-DEC-2009. The patient's IgM was <1:10, her IgG was 5.68 and her serum amylase was 346. The outcome of the patient was not reported. Follow-up information was received which reported that on 11-JAN-2010, the patient developed afebrile bilateral parotitis. It was diagnosed on 11-JAN-2010. On 11-JAN-2010, the patient's IgM was <1:10, serum immunoglobulin G (IgG) was 7.09 and serum amylase was 65. The outcome of the patient was not reported. This is one of several reports from the same source. Additional information is not expected.
Age: 3.0
Sex: F
Vaccine: MMR
Symptoms: Mumps
Clinical narrative: Information has been received from a physician concerning a 15 year old female who on 22-MAY-1996 was vaccinated with first dose of MMR II (route, site, dose and lot number not reported).  On 04-SEP-1997, the patient was vaccinated with second dose of MMR II (route, site, dose and lot number not reported).  On 10-NOV-2009 the patient experienced mumps (the date of diagnosis was reported as 12-NOV-2009).  On 12-NOV-2009 the patient's serum immunoglobulin M test (IgM) was negative, her serum immunoglobulin G test (IgG) was 5.71 and serum amylase 361.  The patient was afebrile and had right parotitis.  The outcome for mumps was not reported.  No further information is available.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Body temperature increased, Mumps, Orchitis, Parotitis, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 12 month old male patient who on an unspecified date was vaccinated with a dose of MMR II (lot number not reported) (reported as number doses received zero). On 16-NOV-2009 the patient experienced mumps. On an unspecified date the patient experienced orchitis. The patient was diagnosed on 06-DEC-2009. It was unknown if the patient was febrile. The outcome of the patient was not reported. Follow-up information was received which reported that on 25-DEC-2009, the patient developed right parotitis with a body temperature of 103. It was diagnosed on 28-DEC-2009. On 28-DEC-2009, the patient's IgM was <1:10, serum immunoglobulin G was 6.58 and serum amylase was 895. The outcome of the patient was not reported. This is one of several reports from the same source. Additional information is not expected.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Body temperature increased, Mumps, Parotitis, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 14 year old female patient who on 15-JUL-1997 was vaccinated with the first dose of MMR II. On 06-DEC-1999 the patient was vaccinated with the second dose of MMR II. There was no lot number reported. On 16-NOV-2009 the patient experienced mumps, patient was diagnosed on 03-JAN-2010. The patient was afebile and experienced parotitis on the left side. The outcome of the patient was not reported. Follow-up information was received which reported that the 14 year old (also reported as 13 year old) patient experienced mumps on 27-NOV-2009 (previously reported on 16-NOV-2009). The patient was diagnosed on 29-NOV-2009. The patient had a fever of 101.5 degree F and right side parotitis. This is one of several reports from the same source. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase normal, Body temperature normal, Cough, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 14 year old male who on 07-AUG-1996 was vaccinated with first dose of MMR II (route, site, dose and lot number not reported).  On 15-JUN-1999, the patient was vaccinated with second dose of MMR II (route, site, dose and lot number not reported).  On 17-NOV-2009, the patient experienced mumps (the date of diagnosis was reported as 13-DEC-2009).  The patient was afebrile and had left parotitis.  The patient's fever count was 36 and his parotitis count was 43.  On 14-Dec-2009, the patient's serum immunoglobulin G test was 5.02 and serum amylase was 111.  The outcome for mumps was not reported.  Follow up information was received which reported that on 02-JAN-2010, the patient experienced mumps (the date of diagnosis was reported as 04-JAN-2010).  The patient was afebrile and had left parotitis.  The patient had other symptom reported as cough for 3 days.  On 04-JAN-2010, the patient's serum immunoglobulin G test was 3.81, serum immunoglobulin M test 0.55 and serum amylase was 68.  The outcome for mumps was not reported.  No further information is available.
Age: 19.0
Sex: M
Vaccine: MMR
Symptoms: Mumps, Parotitis, Swelling
Clinical narrative: Information has been received from a physician concerning a 19 year old male who on an unspecified date was vaccinated with two doses of MMR II (LOT# not reported). On 08-NOV-2009 the patient experienced mumps. On 10-NOV-2009, the patient was diagnosed with mumps. The patient was afebrile and also experienced left parotitis and "lump under left ear". The blood work was done on 10-NOV-2009 and the results indicated IgM 0.47, IgG 5.51, and serum amylase 358. Follow up information has been received concerning a 19 year old (also reported as 4 year old) male who on an unspecified date was vaccinated with two doses of MMR II (LOT# not reported). On 07-DEC-2009 (previously reported as 08-NOV-2009) the patient experienced mumps. On 07-DEC-2009 the patient was afebrile and was diagnosed with mumps (previously reported as 10-NOV-2009). The patient experienced right parotitis. On 07-DEC-2009, lab results showed that IgM was <1:10 and IgG was 4.18. At the time of the report, the patient's outcome was unknown. No further information is available.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase normal, Body temperature normal, Dizziness, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 15 year old male who on 15-MAY-1995 and 24-AUG-1999 was vaccinated with the first and second dose of MMR II (LOT# not reported). On 13-NOV-2009, the patient experienced R parotitis, dizziness and was afebrile. On 18-NOV-2009 the patient experienced mumps. The blood work was done on 13-NOV-2009 and the results indicated IgM <1:10, IgG 4.31, and serum amylase 74. Follow up information has been received concerning a 15 year old (also reported as 14 year old) male who on 15-MAY-1995 and 24-AUG-1999 was vaccinated with the first and second dose of MMR II (LOT# not reported). On 03-NOV-2009 (previously reported as 18-NOV-2009) the patient experienced mumps. On 05-NOV-2009, the patient was afebrile and diagnosed with mumps. The patient had left parotitis. The blood work was done on 09-NOV-2009 and the results indicated IgM <1:10 and IgG 8.11. The results of the blood work on 24-NOV-2009 indicated IgM <1:10 and IgG 8.2. At the time of the report, the patient's outcome was unknown. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Headache, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 15 year old male who on 23-MAY-1995 was vaccinated with a first dose of MMR II (route, site, and lot number not reported). On 05-JAN-1998, the patient was vaccinated with a second dose of MMR II (route, site, and lot number not reported). Subsequently, the patient had a headache for two days and was afebrile. On 10-NOV-2009, the patient experienced mumps (diagnosed on 12-NOV-2009). The patient was afebrile and had left parotitis. On 19-NOV-2009, the patient had an IgM and IgG performed, The results were <1:10 and 8.11 respectively. At the time of the report, the outcome was not reported. On 24-NOV-2009, the patient had an IgM and IgG performed. The results were less than 1:10 and 8.2. No further information is available.
Age: 0.8
Sex: M
Vaccine: MMR
Symptoms: Blood immunoglobulin G decreased, Blood immunoglobulin M decreased, Mumps, Pain in jaw, Parotitis
Clinical narrative: Information has been received from a physician concerning a 9 months boy who on an unspecified date was vaccinated with MMR II.  On 28-NOV-2009, the patient experienced mumps.  It was diagnosed on 04-DEC-2009 that the patient was afebrile.  It was also reported that the patient had lower jaw pain.  At the time of this report, the patient's outcome was not reported.  Follow-up information was received from the physician indicating that on 31-DEC-2009, the patient developed mumps.  It was diagnosed on 31-DEC-2009 that the patient had bilateral parotitis.  The first blood work on 31-DEC-2009 revealed IgM <1:10, and IgG 1.42.  No further information is available.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Mumps, Parotitis, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 17 year old male who on 19-JUN-1996 was vaccinated with a first dose of MMR II.  On 08-JUN-1998, the patient was vaccinated with a second dose of MMR II (routes, site and lots number were not reported).  The patient's fever count was 82 and his parotitis count was 100.  On 13-NOV-2009 the patient's serum immunoglobulin M was negative, serum immunoglobulin G was 3.56 and serum amylase was 89.  On 13-NOV-2009 the patient was diagnosed with mumps.  On 14-NOV-2009 the patient experienced right parotitis.  The patient was afebrile.  The outcome for mumps was not reported.  Follow up information has been received concerning the 17 year old male patient who on 19-JUN-1996 and on 08-JUN-1998 was vaccinated with the first and second doses of MMR II (route and lot # unknown), respectively.  On 28-NOV-2009 the patient experienced mumps (he was diagnosed on 01-DEC-2009).  The patient was afebrile and had R parotitis.  On 01-DEC-2009, a first blood work was performed with a result of IgM was <1:10, IgG was 5.01 and serum amylase test was 178.  At the time of the report the patient's outcome was unknown.  No further information is available.
Sex: F
Vaccine: MMR
Symptoms: Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a nurse concerning a female who was vaccinated with a dose of MMR II (lot# 663519/1771X, 0.5ml, SC) on an unspecified date. The patient experienced a red, hot and swollen area the size of a golf ball on her arm, at the injection site, and a fever about 2 weeks after receiving the vaccine. The patient sought medical attention by phone. At the report time the outcome was unknown. This is one of several reports received from the same source. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase normal, Mumps, Mumps antibody test positive, Parotitis
Clinical narrative: Information has been received from a physician concerning a 14 year old male who on 16-JUL-1997 was vaccinated with a first dose of MMR II.  On 05-OCT-2000, the patient was vaccinated with a second dose of MMR II (route, site and lots number were not reported).  On 17-NOV-2009 the patient experienced right parotitis.  The patient was afebrile.  On 27-NOV-2009, lab tests revealed: IgM less than 1:10, IgG 7.3, and serum amylase 137.  On 14-JAN-2010 the patient was diagnosed with mumps.  Follow up information was received from the physician reporting that the patient was 13 years old.  On 14-JAN-2010, the patient experienced right parotitis.  On 14-JAN-2010, lab tests revealed: IgM 0.26, IgG 2.8, and serum amylase 68.  On 12-JAN-2010 the patient was diagnosed with mumps.  The outcome for mumps was not reported.  This is one of several reports from the same source.  No further information is available.
Age: 5.0
Sex: F
Vaccine: MMR
Symptoms: Oropharyngeal pain, Parotitis
Clinical narrative: Information has been received from a nurse concerning a 5 year old female who on 14-SEP-2005 was vaccinated with the first dose of MMR II. On 15-JUL-2009, the patient received the second dose of MMR II (0.5ml, SC, lot# 663100/1672X). On 27-JUL-2009, the patient experienced parotitis. The patient was treated with supportive care including TYLENOL with CODEINE and cold packs. At the time of the report the patient had not recovered. Follow-up information has been received from the registered nurse concerning a 5 year old female who on 15-JUL-2009 at 15:00, was vaccinated with the second dose of MMR II (SC, 0.5ml, lot# 663100/1672X) in her right thigh. On 26-JUL-2009, the patient experienced sore throat, marked right parotid swelling approximately 6x5 cm to inferior ear and posterior auricular area. On 04-AUG-2009, the patient recovered. No further information is available.
Sex: F
Vaccine: MMR
Symptoms: Antineutrophil cytoplasmic antibody, No therapeutic response, Unevaluable event
Clinical narrative: Information has been received from a medical assistant concerning an adult female who was vaccinated with a dose of MMR II on an unspecified date. The patient had titers drawn on an unspecified date. The patient had MMR II as a child (unknown how many doses or when) and was negative for mumps. No adverse effects noted. At the report time the outcome was unknown. This is one of several reports received from the same source. Additional information has been requested.
Age: 3.0
Sex: F
Vaccine: MMR
Symptoms: Mumps
Clinical narrative: Information has been received from a physician concerning a 9 year old female patient who on 03-JAN-2002 was vaccinated with the first dose of MMR II. The patient received the second dose of MMR II on 09-NOV-2004. On 08-JAN-2010, the patient experienced mumps. The date diagnosed was reported as 10-JAN-2010. The patient was afebrile and had left parotitis. The outcome for mumps was not reported. No further information is available.
Age: 1.02
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Ecchymosis, Fall, Head injury
Clinical narrative: Information has been received from a physician via medical records concerning a 12 month old male with umbilical hernia and a history of gastrooesophageal reflux disease, stridor inspiratory, mild laryngomalacia, bilateral true vocal fold nodules, diarrhea, irritability, pyloric stenosis, pylorectomy and facial rash (WAES #0801USA00092); and upper respiratory infection, possible coagulopathy, diaper rash, eczema, and gastroenteritis (all reported in WAES 0907USA05357) who on 29-JUN-2009, at 16:24, was vaccinated SQ in the right thigh with a first 0.5 ml dose of MMR II (Lot #663897/0153Y). Secondary suspect therapy included a first 0.5 ml dose of VARIVAX (Lot #663815/0266Y) administered SQ in the left thigh. Concomitant therapy included HAVRIX (Lot # AHAVB336D) IM in the right thigh. On 29-JUN-2009, at 17:31, the baby presented to the emergency room with head injury. Mother stated that aunt informed her the patient was walking and fell forward into a statue. Patient had been acting like himself. Patient was playful and running around in room. Parents concerned because the patient had small bruise to forehead. Physical examination showed mild ecchymosis to middle of forehead above nasal bridge. He was diagnosed with head injury. Since the patient's condition was stable, he was discharged to home on the same day, at 19:50. If symptoms worsened or changed, the patient would return to the emergency room. The patient was instructed to follow up with his primary care physician. The outcome of the patient was not reported. This is one of several reports regarding the same patient. Additional information is not expected.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Laboratory test abnormal, Lymphadenopathy, Mumps, Oropharyngeal pain, Parotitis
Clinical narrative: Information has been received from a physician concerning a 9 year old female who on 25-JAN-2001 was vaccinated with the first dose of MMR II, and the second dose (HSA) on 03-MAY-2004. On 05-DEC-2009 the patient developed mumps. She was diagnosed with mumps on 06-DEC-2009. The patient did not have a fever. The patient had swollen glands, sore throat and parotitis and the parotitis count was 121. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
Age: 10.0
Sex: U
Vaccine: MMR
Symptoms: Mumps antibody test, No therapeutic response
Clinical narrative: Information has been received from a pharmacy student concerning a patient who on an unspecified date, in the past, was vaccinated with 1 or 2 doses of MMR II. On an unspecified date, the patient had low titers to mumps. It was unknown if the patient sought medical attention. At the time of this report, the patient's outcome was unknown. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Allergy to vaccine
Clinical narrative: Information has been received from a pharmacist that heard about a child who on an unspecified date was vaccinated with a dose of MMR II. The pharmacist did not know who the patient was or what the reaction was but he thought the child might had had a hypersensitivity reaction. The reporter stated. "It was not a reaction such as autism. I believed the child had an immune response to the vaccine which showed he was allergic to it." It was unknown if the patient sought medical attention. The pharmacist had no other details because the parent who told him about it did not want to provide anymore information to him. At the time of this report, the patient's outcome was unknown. No further information is available.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Local swelling, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 13 year old female patient who on 20-OCT-1998 was vaccinated with the first dose of MMR II. The patient received the second dose of MMR II on 25-JAN-2001. On 15-JAN-2010, the patient experienced mumps. The date diagnosed was reported as 17-JAN-2010. The patient's symptoms included left parotitis and left side neck swollen. The outcome of the patient was unknown. No further information is available.
Age: 32.0
Sex: F
Vaccine: MMR
Symptoms: No therapeutic response, Rubella antibody negative
Clinical narrative: Information has been received from a Registered Nurse (R.N.) concerning a 32 year old female patient with allergy to promethazine with codeine and history of migraine who on an unspecified date, in the past, was vaccinated with a dose of MMR II.  Concomitant therapy included LEXAPRO and LOESTRIN.  It was reported that the patient had negative titers for rubella.  The patient sought unspecified medical attention.  The office did not have the patient's immunization records so she did not know if the patient had received 1 or 2 doses of MMR II.  At the time of the report the patient had negative titers for rubella.  Follow up information has been received from a registered nurse who stated she spoke with the 32 year old female and she did not have any adverse reaction to MMR II.  Additional information is not expected.